R. Drozdz et An. Eberle, BINDING-SITES FOR MELANIN-CONCENTRATING HORMONE (MCH) IN BRAIN SYNAPTOSOMES AND MEMBRANES FROM PERIPHERAL-TISSUES IDENTIFIED WITH HIGHLY TRITIATED MCH, Journal of receptor and signal transduction research, 15(1-4), 1995, pp. 487-502
Melanin-concentrating hormone (MCH) is a neuropeptide occurring in the
brain of all vertebrate species. In chromatophores of teleost fishes
it induces pigment granule aggregation. In mammals, however, its physi
ological function is not yet clear. Attempts to identify the site(s) o
f its action by binding analysis failed because radioiodinated MCH wit
h the natural sequence was devoid of biological activity. We have now
synthesized an analogue of rat/human MCH, [Pra(4,8,12,19)]-MCH, contai
ning four L-propargylglycine (Pra) residues in positions 4, 8, 12, and
19 for catalytic tritiation to norvaline ([H-3(4)]Nva) residues, each
of which containing four tritium atoms. The resulting [H-3]-MCH ([(H-
3(4))Nva(4,8,12,19)]-MCH) had a specific radioactivity of approx. 12,2
00 GBq/mmol (330 Ci/mmol) and retained a biological activity of 10% as
compared to rat/human MCH when tested in the carp scale assay. A seri
es of qualitative binding studies performed with rat crude membranes f
rom brain and peripheal tissues as well as with rat brain synaptosomes
using the [H-3]-MCH radioligand provided the first evidence for the p
resence of MCH receptors in mammalian tissues. The data showed that sp
ecific binding is present in the hypothalamus, hippocampus and in the
adrenal gland while none was detected in the brain cortex or spleen. O
wing to the tendency of [H-3]-MCH to non-specific binding to tissue, g
lass and plastic surfaces, a saturation binding analysis with this rad
ioligand was not possible.